Coffee consumption and hepatocellular carcinoma in patients with HBeAg negative chronic hepatitis B

被引：1
|
作者：
Chen, Chien-Lin [1 ,2 ]
Chang, Wei-Chuan [3 ]
Hsu, Ching-Sheng [2 ,4 ,5 ]
机构：
[1] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[2] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Internal Med, Div Gastroenterol, Hualien, Taiwan
[3] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan
[4] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Liver Dis Res Ctr, Taipei, Taiwan
[5] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien, Taiwan
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2020年 / 119卷 / 03期
关键词：
D O I：
10.1016/j.jfma.2019.11.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：765 / 766
页数：2
相关论文
共 50 条
  • [21] Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study
    Leung, Winnie Wing-man
    Ho, Suzanne C.
    Chan, Henry L. Y.
    Wong, Vincent
    Yeo, Winnie
    Mok, Tony S. K.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 (06) : 556 - 558
  • [22] Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B
    Rizzetto, M
    Tassopoulos, NC
    Goldin, RD
    Esteban, R
    Santantonio, T
    Heathcote, EJ
    Lagget, M
    Taak, NK
    Woessner, MA
    Gardner, SD
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 173 - 179
  • [23] Efficacy and safety of treatment interruption in patients with HBeAg negative chronic hepatitis B
    Broquetas, Teresa
    Mico, Miquel
    Garcia-Retortillo, Montserrat
    Canete Hidalgo, Nuria
    Puigvehi, Marc
    Coll, Susanna
    Batlle, Marc
    Viu, Ana
    Garrido, Esther
    Romero, Judit
    Jose Hernandez, Juan
    Bessa, Xavier
    Carrion, Jose A.
    JOURNAL OF HEPATOLOGY, 2020, 73 : S860 - S860
  • [24] Evaluation of Serum Cytokines and Chemokines in HBeAg Negative Chronic Hepatitis B Patients
    Cheng, Yan
    Au, Veonice Bijin
    Connolly, John E.
    Lim, Seng Gee
    HEPATOLOGY, 2014, 60 : 1034A - 1034A
  • [25] Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    Lai, CL
    Shouval, D
    Lok, AS
    Chang, TT
    Cheinquer, H
    Goodman, Z
    DeHertogh, D
    Wilber, R
    Zink, RC
    Cross, A
    Colonno, R
    Fernandes, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1011 - 1020
  • [26] Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
    Kwak, Min-Sun
    Cho, Eun Ju
    Jang, Eun Sun
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    DIGESTION, 2011, 84 : 23 - 28
  • [27] Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
    Huang, Rui
    Wang, Jian
    Yan, Xiaomin
    Xia, Juan
    Wu, Chao
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (05) : 618 - 619
  • [28] Impact of liver fibrosis in development of hepatocellular carcinoma in HBeAg negative genotype D patients with chronic hepatitis B treated with nucleos(t)ide analogues
    Pellicellii, Adrian M.
    Vignally, Pascal
    Mazzoni, Ettore
    Izzi, Antonio
    Mecenate, Fabrizio
    Romano, Mario
    Barlattani, Angelo
    Villani, Roberto
    Guarascio, Paolo
    Furlan, Caterina
    Cerasari, Giuseppe
    Bacca, Donato
    D'Ambrosio, Cecilia
    Fondacaro, Lucia
    Miglioresi, Lucia
    Bonaventura, Maria Elena
    Andreoli, Arnaldo
    Barbarini, Giorgio
    HEPATOLOGY, 2012, 56 : 200A - 201A
  • [29] Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: A 5-year population-based cohort study
    Chen, Chien-Lin
    Chang, Wei-Chuan
    Yi, Chih-Hsun
    Hung, Jui-Sheng
    Liu, Tso-Tsai
    Lei, Wei-Yi
    Hsu, Ching-Sheng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (02) : 628 - 635
  • [30] Chronic Hepatitis B and Hepatocellular Carcinoma
    McClune, Amy C.
    Tong, Myron J.
    CLINICS IN LIVER DISEASE, 2010, 14 (03) : 461 - +
12345